95368 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains three hetero rings Bridged systems
4-aryl-2-anilino-pyrimidines
#302Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
#303Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
#304Diazahomoadamantane derivatives and methods of use thereof
#305Luminescent compounds
#306Dinitroxide-type biradical compounds optimized for dynamic nuclear polarization (DNP)
#307Indole and indoline derivatives and methods of use thereof
#308Cyclic anilino—pyridinotriazines
#309HETEROARYL-SUBSTITUTED DIAZATRICYCLOALKANES AND METHODS OF USE THEREOF
#310Nicotinic acetylcholine receptor ligands and the uses thereof
#311Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
#312Nicotinic desensitizers and methods of selecting, testing, and using them
#313Aza-bridged-ring compound
#314Bridged heterocyclic compounds and methods of use
#315NOVEL COMBINATIONS OF NITROGENATED HETEROCYCLIC ANTIBACTERIAL COMPOUNDS WITH OTHER ANTIBACTERIAL COMPOUNDS AND THE USE OF SAME AS DRUGS
#316Nitrogen-containing heterocyclic compounds, their preparation and their use as antibacterial drugs
#317Indole and indoline derivatives and methods of use thereof
#3182,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect
#319Pyrimidine compounds, compositions and methods of use
#320POLYMORPHS OF NICOTINIC INTERMEDIATES
#32110-Substituted Cytisine Derivatives and Methods of Use Thereof
#322Cytisine and Acetylcholine Analogs and Methods of Treating Mood Disorders
#323HIV integrase inhibitors
#3242-alkylbenzoxazole carboxamides as 5HT3 modulators
#325Intermediate compounds useful to prepare dolasetron
#326Therapeutic Agents - 551
#327Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors
#328Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
#329Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof
#330Sinomenine derivatives and preparation and uses thereof
#331Production of Polyketides and Other Natural Products
#332Polymorphic Forms of Dolasetron Base and Processes of Preparing Dolasetron Base, Its Polymorphic Forms and Salt Thereof
#333Aminomethyl azaadamantane derivatives and methods of use thereof
#3344-substituted azaadamantane derivatives and methods of use thereof
#335Acetamide and carboxamide derivatives of azaadamantane and methods of use thereof
#336Azaadamantane ester and carbamate derivatives and methods of use thereof
#337Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#338Substituted pyrimidodiazepines
#3392-alkylbenzoxazole carboxamides as 5-HTmodulators
#340Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
#341Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
#342Azaadamantane derivatives and methods of use
#343Spirocyclic azaadamantane derivatives and methods of use
#344Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
#345Ligands for nicotinic acetylcholine receptors, and methods of making and using them
#346Bridged N-cyclic sulfonamido inhibitors of gamma secretase
#347Antitumoral analogs of ET-743
#348Hemisynthetic method and new compounds
#349Production of polyketides and other natural products
#350Production of polyketides and other natural products
#351HIV integrase inhibitors
#352Nicotinic receptor agonists and analogues and derivatives thereof for the treatment of inflammatory diseases
#353Production of dolasetron
#354Forms of dolasetron mesylate and processes for their preparation
#355Crystalline forms of dolasetron base and processes for preparation thereof
#356Productioin of dolasetron
#357Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
#358Compounds for the treatment of inflammatory disorders and microbial diseases
#359Saframycins, analogues and uses thereof
#360Tricycloundecane compounds useful as modulators of nuclear hormone receptor function
#361Bridged N-cyclic sulfonamido inhibitors of gamma secretase
#362Synthetic process for the manufacture of an ecteinaschidin compound
#363Production of polyketides and other natural products
#364Antitumoral analogs of ET-743
#365Production of polyketides and other natural products
#366Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
#367Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
#368Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
#369Nicotinic receptor agonists for the treatment of inflammatory diseases
#370Beta-carboline compounds and analogues thereof as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
#371Varenicline compound and process of manufacture thereof
#372Macrocyclic flu endonuclease inhibitors